Evolution of pneumococcal serotype epidemiology in Botswana following introduction of 13-valent pneumococcal conjugate vaccine

被引:5
|
作者
Patel, Sweta M. [1 ,2 ]
Shaik-Dasthagirisaheb, Yazdani B. [3 ]
Congdon, Morgan [4 ]
Young, Rebecca R. [5 ]
Patel, Mohamed Z. [6 ]
Mazhani, Tiny [6 ]
Boiditswe, Sefelani [7 ]
Leburu, Tirayaone [7 ]
Lechiile, Kwana [7 ]
Arscott-Mills, Tonya [4 ,6 ,7 ]
Steenhoff, Andrew P. [4 ,6 ,8 ,9 ]
Feemster, Kristen A. [8 ,9 ]
Shah, Samir S. [10 ,11 ]
Cunningham, Coleen K. [12 ]
Pelton, Stephen I. [3 ]
Kelly, Matthew S. [2 ,5 ]
机构
[1] Duke Univ, Div Pulm Allergy & Crit Care Med, Durham, NC 27708 USA
[2] Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA
[3] Boston Univ, Sch Med, Div Pediat Infect Dis, Boston, MA 02118 USA
[4] Childrens Hosp Philadelphia, Div Gen Pediat, Philadelphia, PA 19104 USA
[5] Duke Univ, Div Pediat Infect Dis, Durham, NC USA
[6] Univ Botswana, Fac Med, Dept Paediat & Adolescent Hlth, Gaborone, Botswana
[7] Botswana Univ Pennsylvania Partnership, Gaborone, Botswana
[8] Childrens Hosp Philadelphia, Div Pediat Infect Dis, Philadelphia, PA USA
[9] Childrens Hosp Philadelphia, Dept Pediat, Global Hlth Ctr, Philadelphia, PA 19104 USA
[10] Cincinnati Childrens Med Ctr, Div Hosp Med, Cincinnati, OH USA
[11] Cincinnati Childrens Med Ctr, Div Infect Dis, Cincinnati, OH USA
[12] Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA
来源
PLOS ONE | 2022年 / 17卷 / 01期
基金
美国国家卫生研究院;
关键词
CARRIAGE; CHILDREN;
D O I
10.1371/journal.pone.0262225
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Pneumococcal conjugate vaccines reduce the burden of invasive pneumococcal disease, but the sustained effect of these vaccines can be diminished by an increase in disease caused by non-vaccine serotypes. To describe pneumococcal serotype epidemiology in Botswana following introduction of 13-valent pneumococcal conjugate vaccine (PCV-13) in July 2012, we performed molecular serotyping of 268 pneumococcal strains isolated from 221 children between 2012 and 2017. The median (interquartile range) age of the children included in this analysis was 6 (3,12) months. Fifty-nine percent of the children had received at least one dose of PCV-13 and 35% were fully vaccinated with PCV-13. While colonization by vaccine serotypes steadily declined following PCV-13 introduction, 25% of strains isolated more than 3 years after vaccine introduction were PCV-13 serotypes. We also observed an increase in colonization by non-vaccine serotypes 21 and 23B, which have been associated with invasive pneumococcal disease and antibiotic resistance in other settings.
引用
下载
收藏
页数:9
相关论文
共 50 条
  • [41] Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed) [Prevenar 13®]
    Sean T. Duggan
    Drugs, 2010, 70 : 1973 - 1986
  • [42] Infants at Risk for Invasive Pneumococcal Disease in the 13-Valent Pneumococcal Conjugate Vaccine Era
    Yildirim, Inci
    Pelton, Stephen I.
    CLINICAL INFECTIOUS DISEASES, 2019, 69 (01) : 91 - 92
  • [43] Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine in Children Previously Immunized With 7-valent Pneumococcal Conjugate Vaccine
    Frenck, Robert, Jr.
    Thompson, Allison
    Yeh, Sylvia H.
    London, Arnold
    Sidhu, Mohinder S.
    Patterson, Scott
    Gruber, William C.
    Emini, Emilio A.
    Scott, Daniel A.
    Gurtman, Alejandra
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2011, 30 (12) : 1086 - 1091
  • [44] Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Carriage Among American Indians
    Grant, Lindsay R.
    Hammitt, Laura L.
    O'Brien, Sarah E.
    Jacobs, Michael R.
    Donaldson, Connie
    Weatherholtz, Robert C.
    Reid, Raymond
    Santosham, Mathuram
    O'Brien, Katherine L.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2016, 35 (08) : 907 - 914
  • [45] Pneumococcal 13-valent conjugate vaccine for the prevention of invasive pneumococcal disease in children and adults
    Gladstone, Rebecca A.
    Jefferies, Johanna M.
    Faust, Saul N.
    Clarke, Stuart C.
    EXPERT REVIEW OF VACCINES, 2012, 11 (08) : 889 - 902
  • [46] Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease After Introduction Into Routine Pediatric Use
    Baxter, Roger
    Aukes, Laurie
    Pelton, Stephen, I
    Yee, Arnold
    Klein, Nicola P.
    Gruber, William C.
    Scott, Daniel A.
    Center, Kimberly J.
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2021, 10 (02) : 141 - 150
  • [47] Clinical and Bacteriological Analysis of Pediatric Pneumococcal Meningitis after 13-Valent Pneumococcal Conjugate Vaccine Introduction in Japan
    Kurihara, Erika
    Takeshita, Kenichi
    Tanaka, Saori
    Takeuchi, Noriko
    Ohkusu, Misako
    Hishiki, Haruka
    Ishiwada, Naruhiko
    MICROBIOLOGY SPECTRUM, 2022, 10 (02):
  • [48] Decrease of invasive pneumococcal disease (IPD) in adults after introduction of pneumococcal 13-valent conjugate vaccine in Spain
    Camara, Jordi
    Maria Marimon, Jose
    Cercenado, Emilia
    Larrosa, Nieves
    Quesada, Maria Dolores
    Fontanals, Dionisia
    Cubero, Meritxell
    Perez-Trallero, Emilio
    Fenoll, Asuncion
    Linares, Josefina
    Ardanuy, Carmen
    PLOS ONE, 2017, 12 (04):
  • [49] Pneumococcal meningitis in adults in 2014–2018 after introduction of pediatric 13-valent pneumococcal conjugate vaccine in Japan
    Bin Chang
    Kosuke Tamura
    Hiroyuki Fujikura
    Hiroshi Watanabe
    Yoshinari Tanabe
    Koji Kuronuma
    Jiro Fujita
    Kengo Oshima
    Takaya Maruyama
    Shuichi Abe
    Kei Kasahara
    Junichiro Nishi
    Tetsuya Kubota
    Yuki Kinjo
    Yusuke Serizawa
    Reiko Shimbashi
    Munehisa Fukusumi
    Tomoe Shimada
    Tomimasa Sunagawa
    Motoi Suzuki
    Kazunori Oishi
    Scientific Reports, 12
  • [50] Pneumococcal Carriage in Burkina Faso After 13-Valent Pneumococcal Conjugate Vaccine Introduction and Before a Schedule Change
    Childs, Lana
    Ouedraogo, Issa
    Zoma, Robert Lamoussa
    Tarbangdo, T. Felix
    Sawadogo, Guetwende
    Ake, H. Flavien
    Ouangraoua, Soumeya
    Sanou, Soufiane
    Tran, Theresa
    Velusamy, Srinivasan
    Adebanjo, Tolulope
    Van Beneden, Chris A.
    Mcgee, Lesley
    Kobayashi, Miwako
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (06):